Lojo Rial Carlos, Ozainne Florian, Fehlmann Christophe, Von Düring Stephan, Cottet Philippe
Emergency Medicine Department, St Thomas' Hospital, London (UK).
Service d'ambulance A.C.E. Ambulances, Route de Jussy 2, 1225 Chêne-Bourg.
Rev Med Suisse. 2020 Mar 18;16(686):553-556.
Since 2018, a new analgesic drug has been made available in Switzerland : methoxyflurane. This halogenated gas, controlled by the patient, offers a very effective analgesic effect comparable to opiates. Known since the 1960s and used mainly in pre-hospital emergency medicine in Australia and New Zealand, its use in Europe is increasing alongside standard analgesic treatments in the traumatic setting. Administered by inhalation, it does not require an intravenous access, which is ideal in prehospital emergency situations. This treatment could be used for the management of acute pain of various origins, such as renal lithiasis, or to facilitate different procedures, such as closed fracture reduction or chest tube insertion. Its indications are growing and its use will probably become commonplace with clinicians in a near future.
自2018年以来，瑞士已开始使用一种新型镇痛药：甲氧氟烷。这种由患者自行控制的卤化气体具有与阿片类药物相当的非常有效的镇痛效果。自20世纪60年代以来为人所知，主要在澳大利亚和新西兰的院前急救医学中使用，在欧洲，其使用量正随着创伤环境中的标准镇痛治疗而增加。通过吸入给药，不需要静脉通路，这在院前紧急情况下非常理想。这种治疗方法可用于管理各种原因引起的急性疼痛，如肾结石，或促进不同的操作，如闭合性骨折复位或胸腔置管。其适应证正在增加，在不久的将来，临床医生使用它可能会变得很普遍。
